株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

臨床試験向け画像の世界市場予測 ~2021年:製品・サービス・モダリティ (CT・MRI・PET・超音波・心エコー検査・X線)・エンドユーザー別

Clinical Trial Imaging Market by Product & Services (Software), Modality (CT, MRI, PET, Ultrasound, Echocardiography, X-Ray), End User (Pharmaceutical Companies, Biotechnology Companies, CROs, Medical Device Manufacturers) - Global Forecast to 2021

発行 MarketsandMarkets 商品コード 408725
出版日 ページ情報 英文 125 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.20円で換算しております。
Back to Top
臨床試験向け画像の世界市場予測 ~2021年:製品・サービス・モダリティ (CT・MRI・PET・超音波・心エコー検査・X線)・エンドユーザー別 Clinical Trial Imaging Market by Product & Services (Software), Modality (CT, MRI, PET, Ultrasound, Echocardiography, X-Ray), End User (Pharmaceutical Companies, Biotechnology Companies, CROs, Medical Device Manufacturers) - Global Forecast to 2021
出版日: 2016年12月13日 ページ情報: 英文 125 Pages
概要

臨床試験向け画像製品・サービスの市場は2016年から2021年にかけて6.7%のCAGR (年間複合成長率) で推移し、2016年の7億7340万米ドルから、2021年には10億6970万米ドルの規模に成長すると予測されています。R&D支出の拡大、医薬・バイオテクノロジー産業の成長、CROの増加などの要因が同市場の成長を推進しています。

当レポートでは、世界の臨床試験向け画像製品・サービスの市場を調査し、市場および製品・サービスの概要、関連法規制、世界の臨床試験の動向、市場への各種影響因子と市場機会の分析、製品&サービス・モダリティ・エンドユーザー・地域/主要国別の動向と市場規模の推移と予測、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 市場概要
  • 市場の実績:製品・サービス別
  • 市場の実績・予測:モダリティ別
  • 市場の実績・予測:エンドユーザー別
  • 地域概要
  • ライフサイクル分析:地域別

第5章 臨床試験向け画像関連製品・サービスの世界市場:概要

  • イントロダクション
  • 市場力学
    • 推進要因
    • 抑制要因
    • 機会
    • 課題
  • 近年の市場動向
  • 法規制シナリオ
  • 臨床試験:世界のシナリオ

第6章 臨床試験向け画像関連製品・サービスの世界市場:製品・サービス別

  • イントロダクション
  • サービス
    • オペレーショナルイメージング
    • リードアナリシス
    • システム&テクニカルサポート
    • 臨床試験設計コンサルティング
  • ソフトウェア

第7章 臨床試験向け画像関連製品・サービスの世界市場:モダリティ別

  • イントロダクション
  • CT
  • MRI
  • 超音波
  • PET
  • X線
  • 心エコー検査
  • その他

第8章 臨床試験向け画像関連製品・サービスの世界市場:エンドユーザー別

  • イントロダクション
  • 医薬品企業
  • バイオテクノロジー企業
  • 医療機器製造業者
  • CRO
  • 学術・政府研究機関
  • その他

第9章 臨床試験向け画像関連製品・サービスの世界市場:地域分析

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
  • アジア
  • その他の地域

第10章 競合環境

  • イントロダクション
  • 戦略概要
  • 競合状況・動向
  • 主要企業
    • 合意・提携・協力
    • 拡張
    • 買収
    • 製品&サービスの投入・アップグレード

第11章 企業プロファイル

  • イントロダクション
  • BIOCLINICA, INC.
  • PAREXEL INTERNATIONAL CORPORATION
  • ICON PLC
  • BIOMEDICAL SYSTEMS CORPORATION
  • BIOTELEMETRY, INC.
  • CARDIOVASCULAR IMAGING TECHNOLOGIES, LLC
  • INTRINSIC IMAGING LLC
  • IXICO PLC
  • RADIANT SAGE LLC
  • WORLDCARE CLINICAL, LLC
    • イントロダクション
    • 製品・サービス
    • 戦略
    • 発展動向、など

第12章 付録

目次
Product Code: MD 4818

The global clinical trial imaging market is projected to reach USD 1069.7 million by 2021 from USD 773.4 million in 2016, at a CAGR of 6.7% from 2016 to 2021. Increase in R&D spending and growth in the pharmaceutical and biotechnology industries and the increasing number of contract research organizations are the key drivers for the growth of the clinical trial imaging market.

Developing markets in Asia such as Japan, China, and India are lucrative markets for clinical trial imaging. Asia is expected to grow at the highest CAGR in the forecast period. The growth in the Asian clinical trial imaging market is driven by the growth in pharmaceutical & biotechnology industries and increase in R&D spending in the region.

In this report, the global clinical trial imaging market is broadly segmented by product and service, modality, end user, and region. On the basis of product and service, the clinical trial imaging market is segmented into software and services. Services segment is classified into operational imaging services, reader services, systems & technology, and design consulting. The service segment is expected to account for the largest share of the clinical trial imaging market in 2016. The large share of this segment can primarily be attributed to high cost of the imaging equipment, which is leading to increased outsourcing of imaging clinical trial by pharmaceutical, biotechnology, and medical device manufacturers to service providers.

On the basis of modality, the clinical trial imaging market is broadly classified into CT, MRI, PET, ultrasound, ECHO, x-ray, and other modalities. In 2016, the CT segment is expected to account for the largest share of the global clinical trial imaging market. The large share of this segment is attributed to the high advantages of CT in screenings for cancer (tumors), injuries, and abnormalities inside the body.

On the basis of end user, the clinical trial imaging market is categorized into pharmaceutical companies, biotechnology companies, medical device manufacturers, contract research organizations, academic and government research institutes, and other end users. In 2016, Pharmaceutical companies form the largest end-user segment of the clinical trial imaging market. Increased R&D budgets of pharmaceutical companies are the primary growth driver for this end-user segment.

Collaboration, Partnership, and Agreement was the dominant strategy adopted by key industry participants to increase their market share and cater to unmet needs.

Research Coverage:

From an insight perspective, this research report focuses on qualitative data, market size, and growth of various segments and sub-segments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats), winning imperatives, and burning issues. The report also offers market sizes and data on the growth of various segments in the industry. It focuses on emerging and high-growth segments, high-growth regions, and initiatives of governments. The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on key players in the clinical trial imaging market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

From an insight perspective, this research report focuses on various levels of analysis-industry analysis (industry trends) and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the single-use bioprocessing market; high-growth regions; and market drivers, restraints, and opportunities.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on products offered by the top players in the clinical trial imaging market
  • Product Development/Innovation: Detailed insights on the upcoming technologies, research & development activities, and new product launches in the clinical trial imaging market
  • Market Development: Comprehensive information about lucrative emerging markets-the report analyzes the markets for clinical trial imaging products across various regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the clinical trial imaging market
  • Competitive Assessment: In-depth assessment of market ranking, strategies, products, and manufacturing capabilities of the leading players in the clinical trial imaging market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED IN THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATION
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.3. MARKET RANK ESTIMATION
    • 2.3.1. KEY DATA FROM SECONDARY SOURCES
    • 2.3.2. KEY DATA FROM PRIMARY SOURCES
    • 2.3.3. KEY INDUSTRY INSIGHTS
    • 2.3.4. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. CLINICAL TRIAL IMAGING: MARKET OVERVIEW
  • 4.2. CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2016
  • 4.3. CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2016 VS. 2021
  • 4.4. CLINICAL TRIAL IMAGING MARKET SIZE, BY END USER, 2016 VS. 2021
  • 4.5. GEOGRAPHIC SNAPSHOT OF THE CLINICAL TRIAL IMAGING MARKET
  • 4.6. LIFE CYCLE ANALYSIS, BY REGION

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increase in R&D spending
      • 5.2.1.2. Growth in the pharmaceutical and biotechnology industries
      • 5.2.1.3. Increasing number of CROs
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. High implementation cost of imaging systems
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Emerging economies
      • 5.2.3.2. Development of innovative imaging modalities, contrast agents, molecular probes, and radiopharmaceuticals
    • 5.2.4. CHALLENGES
      • 5.2.4.1. High cost of clinical trials
      • 5.2.4.2. High cost of PET
  • 5.3. RECENT MARKET TRENDS
    • 5.3.1. RISING DEMAND FOR MULTIMODALITY IMAGING TECHNOLOGY IN CLINICAL TRIALS
  • 5.4. REGULATORY SCENARIO
  • 5.5. CLINICAL TRIALS: GLOBAL SCENARIO

6. CLINICAL TRIAL IMAGING MARKET, BY PRODUCT AND SERVICE

  • 6.1. INTRODUCTION
  • 6.2. SERVICES
    • 6.2.1. OPERATIONAL IMAGING SERVICES
    • 6.2.2. READ ANALYSIS SERVICES
    • 6.2.3. SYSTEM AND TECHNICAL SUPPORT SERVICES
    • 6.2.4. TRIAL DESIGN CONSULTING SERVICES
  • 6.3. SOFTWARE

7. CLINICAL TRIAL IMAGING MARKET, BY MODALITY

  • 7.1. INTRODUCTION
  • 7.2. COMPUTED TOMOGRAPHY
  • 7.3. MAGNETIC RESONANCE IMAGING
  • 7.4. ULTRASOUND
  • 7.5. POSITRON EMISSION TOMOGRAPHY
  • 7.6. X-RAY
  • 7.7. ECHOCARDIOGRAPHY
  • 7.8. OTHER MODALITIES

8. CLINICAL TRIAL IMAGING MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. PHARMACEUTICAL COMPANIES
  • 8.3. BIOTECHNOLOGY COMPANIES
  • 8.4. MEDICAL DEVICE MANUFACTURERS
  • 8.5. CONTRACT RESEARCH ORGANIZATIONS
  • 8.6. ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES
  • 8.7. OTHER END USERS

9. CLINICAL TRIAL IMAGING MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
    • 9.2.2. CANADA
  • 9.3. EUROPE
  • 9.4. ASIA
  • 9.5. REST OF THE WORLD (ROW)

10. COMPETITIVE LANDSCAPE

  • 10.1. INTRODUCTION
  • 10.2. STRATEGIC OVERVIEW
  • 10.3. COMPETITIVE SITUATION AND TRENDS
  • 10.4. LEADING PLAYERS IN THE CLINICAL TRIAL IMAGING MARKET
    • 10.4.1. AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
    • 10.4.2. EXPANSION
    • 10.4.3. ACQUISITION
    • 10.4.4. PRODUCT AND SERVICE LAUNCHES & PRODUCT UPGRADES

11. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 11.1. INTRODUCTION
  • 11.2. BIOCLINICA, INC.
  • 11.3. PAREXEL INTERNATIONAL CORPORATION
  • 11.4. ICON PLC
  • 11.5. BIOMEDICAL SYSTEMS CORPORATION
  • 11.6. BIOTELEMETRY, INC.
  • 11.7. CARDIOVASCULAR IMAGING TECHNOLOGIES, LLC
  • 11.8. INTRINSIC IMAGING LLC
  • 11.9. IXICO PLC
  • 11.10. RADIANT SAGE LLC
  • 11.11. WORLDCARE CLINICAL, LLC

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. OTHER DEVELOPMENTS
  • 12.4. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.5. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.6. AVAILABLE CUSTOMIZATIONS
  • 12.7. RELATED REPORTS
  • 12.8. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: PHASES OF CLINICAL TRIALS
  • TABLE 2: GLOBAL SCENARIO OF CLINICAL TRIALS TILL 2015
  • TABLE 3: CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 4: CLINICAL TRIAL IMAGING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 5: CLINICAL TRIAL IMAGING SERVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 6: NORTH AMERICA: CLINICAL TRIAL IMAGING SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 7: OPERATIONAL IMAGING SERVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 8: NORTH AMERICA: OPERATIONAL IMAGING SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 9: READ ANALYSIS SERVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 10: NORTH AMERICA: READ ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 11: SYSTEM AND TECHNICAL SUPPORT SERVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 12: NORTH AMERICA: SYSTEM AND TECHNICAL SUPPORT SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 13: TRIAL DESIGN CONSULTING SERVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 14: NORTH AMERICA: TRIAL DESIGN CONSULTING SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 15: CLINICAL TRIAL IMAGING SOFTWARE MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 16: NORTH AMERICA: CLINICAL TRIAL IMAGING SOFTWARE MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 17: CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2014-2021 (USD MILLION)
  • TABLE 18: CLINICAL TRIAL IMAGING MARKET SIZE FOR CT, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 19: NORTH AMERICA: CLINICAL TRIAL IMAGING MARKET SIZE FOR CT, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 20: CLINICAL TRIAL IMAGING MARKET SIZE FOR MRI, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 21: NORTH AMERICA: CLINICAL TRIAL IMAGING MARKET SIZE FOR MRI, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 22: CLINICAL TRIAL IMAGING MARKET SIZE FOR ULTRASOUND, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: NORTH AMERICA: CLINICAL TRIAL IMAGING MARKET SIZE FOR ULTRASOUND, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 24: CLINICAL TRIAL IMAGING MARKET SIZE FOR PET, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 25: NORTH AMERICA: CLINICAL TRIAL IMAGING MARKET SIZE FOR PET, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 26: CLINICAL TRIAL IMAGING MARKET SIZE FOR X-RAY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 27: NORTH AMERICA: CLINICAL TRIAL IMAGING MARKET SIZE FOR X-RAY, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 28: CLINICAL TRIAL IMAGING MARKET SIZE FOR ECHOCARDIOGRAPHY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 29: NORTH AMERICA: CLINICAL TRIAL IMAGING MARKET SIZE FOR ECHOCARDIOGRAPHY, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 30: CLINICAL TRIAL IMAGING MARKET SIZE FOR OTHER MODALITIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 31: NORTH AMERICA: CLINICAL TRIAL IMAGING MARKET SIZE FOR OTHER MODALITIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 32: CLINICAL TRIAL IMAGING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 33: CLINICAL TRIAL IMAGING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 34: NORTH AMERICA: CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 35: CLINICAL TRIAL IMAGING MARKET SIZE FOR PHARMACEUTICAL COMPANIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 36: NORTH AMERICA: CLINICAL TRIAL IMAGING MARKET SIZE FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 37: CLINICAL TRIAL IMAGING MARKET SIZE FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 38: NORTH AMERICA: CLINICAL TRIAL IMAGING MARKET SIZE FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 39: CLINICAL TRIAL IMAGING MARKET SIZE FOR MEDICAL DEVICE MANUFACTURERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 40: NORTH AMERICA: CLINICAL TRIAL IMAGING MARKET SIZE FOR MEDICAL DEVICE MANUFACTURERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 41: CLINICAL TRIAL IMAGING MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 42: NORTH AMERICA: CLINICAL TRIAL IMAGING MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS , BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 43: CLINICAL TRIAL IMAGING MARKET SIZE FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 44: NORTH AMERICA: CLINICAL TRIAL IMAGING MARKET SIZE FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 45: CLINICAL TRIAL IMAGING MARKET SIZE FOR OTHER END USERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 46: NORTH AMERICA: CLINICAL TRIAL IMAGING MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 47: CLINICAL TRIAL IMAGING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 48: NORTH AMERICA: CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 49: NORTH AMERICA: CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 50: NORTH AMERICA: CLINICAL TRIAL IMAGING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 51: NORTH AMERICA: CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2014-2021 (USD MILLION)
  • TABLE 52: NORTH AMERICA: CLINICAL TRIAL IMAGING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 53: U.S.: CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 54: U.S.: CLINICAL TRIAL IMAGING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 55: U.S.: CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2014-2021 (USD MILLION)
  • TABLE 56: U.S.: CLINICAL TRIAL IMAGING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 57: CANADA: CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 58: CANADA: CLINICAL TRIAL IMAGING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 59: CANADA: CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2014-2021 (USD MILLION)
  • TABLE 60: CANADA: CLINICAL TRIAL IMAGING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 61: EUROPE: CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 62: EUROPE: CLINICAL TRIAL IMAGING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 63: EUROPE: CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2014-2021 (USD MILLION)
  • TABLE 64: EUROPE: CLINICAL TRIAL IMAGING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 65: ASIA: CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 66: ASIA: CLINICAL TRIAL IMAGING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 67: ASIA: CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2014-2021 (USD MILLION)
  • TABLE 68: ASIA: CLINICAL TRIAL IMAGING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 69: ROW: CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 70: ROW: CLINICAL TRIAL IMAGING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 71: ROW: CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2014-2021 (USD MILLION)
  • TABLE 72: ROW: CLINICAL TRIAL IMAGING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 73: RANK OF COMPANIES IN THE GLOBAL CLINICAL TRIAL IMAGING MARKET, 2015
  • TABLE 74: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2013-2016
  • TABLE 75: EXPANSIONS, 2013-2016
  • TABLE 76: ACQUISITIONS, 2013-2016
  • TABLE 77: PRODUCT AND SERVICE LAUNCHES & PRODUCT UPGRADES, 2013-2016

LIST OF FIGURES

  • FIGURE 1: CLINICAL TRIAL IMAGING MARKET SEGMENTATION
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 5: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 8: CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2016 VS. 2021 (USD MILLION)
  • FIGURE 9: CLINICAL TRIAL IMAGING MARKET SIZE, BY END USER, 2016 VS. 2021 (USD MILLION)
  • FIGURE 10: GEOGRAPHIC SNAPSHOT OF THE CLINICAL TRIAL IMAGING MARKET
  • FIGURE 11: EMERGING ECONOMIES OFFER SIGNIFICANT GROWTH OPPORTUNITIES FOR PLAYERS IN THE CLINICAL TRIAL IMAGING MARKET
  • FIGURE 12: SERVICES SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE CLINICAL TRIAL IMAGING MARKET IN 2016
  • FIGURE 13: PET MODALITY SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 14: PHARMACEUTICAL COMPANIES TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2016
  • FIGURE 15: ASIA TO REGISTER THE HIGHEST GROWTH RATE FROM 2016 TO 2021
  • FIGURE 16: ASIA OFFERS SIGNIFICANT GROWTH OPPORTUNITIES IN THE FORECAST PERIOD
  • FIGURE 17: INCREASE IN R&D SPENDING WILL DRIVE THE GROWTH OF THE CLINICAL TRIAL IMAGING MARKET
  • FIGURE 18: CLINICAL TRIAL IMAGING SERVICES TO FORM THE LARGEST SEGMENT IN 2016
  • FIGURE 19: CT SEGMENT TO DOMINATE THE CLINICAL TRIAL IMAGING MARKET IN 2016
  • FIGURE 20: PHARMACEUTICAL COMPANIES TO ACCOUNT FOR THE LARGEST SHARE OF THE CLINICAL TRIAL IMAGING MARKET IN 2016
  • FIGURE 21: NUMBER OF BIOTECHNOLOGY AND PHARMACEUTICAL PATENTS GRANTED IN 2012, BY REGION
  • FIGURE 22: NORTH AMERICA TO DOMINATE THE CLINICAL TRIAL IMAGING MARKET DURING THE FORECAST PERIOD
  • FIGURE 23: CLINICAL TRIAL IMAGING MARKET IN ASIA EXPECTED TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 24: NORTH AMERICA: CLINICAL TRIAL IMAGING MARKET SNAPSHOT
  • FIGURE 25: ASIA: CLINICAL TRIAL IMAGING MARKET SNAPSHOT
  • FIGURE 26: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS IS THE KEY GROWTH STRATEGY ADOPTED BY PLAYERS IN THE CLINICAL TRIALS IMAGING MARKET
  • FIGURE 27: BATTLE FOR MARKET SHARE: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS: THE KEY STRATEGIES ADOPTED BY PLAYERS BETWEEN JANUARY 2013 AND OCTOBER 2016
  • FIGURE 28: GEOGRAPHIC REVENUE MIX OF THE TOP THREE MARKET PLAYERS 95  
  • FIGURE 30: COMPANY SNAPSHOT: PAREXEL INTERNATIONAL CORPORATION
  • FIGURE 31: COMPANY SNAPSHOT: ICON PLC
  • FIGURE 32: COMPANY SNAPSHOT: BIOTELEMETRY, INC.
  • FIGURE 33: COMPANY SNAPSHOT: IXICO PLC
Back to Top